The advancement and adoption of sophisticated diagnostic technologies, including Polymerase Chain Reaction (PCR) and Enzyme-Linked Immunosorbent Assay (ELISA), are also pivotal to market growth. These technologies enable swift and accurate detection of bacterial pathogens, allowing aqua culturists to respond promptly to health threats that could devastate stock and operations.